Diabetes Research Envisioned and Accomplished in Manitoba (DREAM) Research Theme, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada.
Department of Physiology & Pathophysiology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Am J Physiol Endocrinol Metab. 2024 Oct 1;327(4):E552-E562. doi: 10.1152/ajpendo.00257.2024. Epub 2024 Aug 28.
Type 1 diabetes (T1D) is a chronic metabolic disease resulting from an autoimmune destruction of pancreatic beta cells. Beta cells activate various stress responses during the development of T1D, including senescence, which involves cell cycle arrest, prosurvival signaling, and a proinflammatory secretome termed the senescence-associated secretory phenotype (SASP). We previously identified growth and differentiation factor 15 (GDF15) as a major SASP factor in human islets and human EndoC-βH5 beta cells in a model of DNA damage-mediated senescence that recapitulates features of senescent beta cells in T1D. Soluble GDF15 has been shown to exert protective effects on human and mouse beta cells during various forms of stress relevant to T1D; therefore, we hypothesized that secreted GDF15 may play a prosurvival role during DNA damage-mediated senescence in human beta cells. We found that elevated GDF15 secretion was associated with endogenous senescent beta cells in an islet preparation from a T1D donor, supporting the validity of our DNA damage model. Using antibody-based neutralization, we found that secreted endogenous GDF15 was not required for senescent human islet or EndoC cell viability. Rather, neutralization of GDF15 led to reduced expression of specific senescence-associated genes, including itself and the prosurvival gene BCL2-like protein 1 (). Taken together, these data suggest that SASP factor GDF15 is not required to sustain senescent human islet viability, but it is required to maintain senescence-associated transcriptional responses. Beta cell senescence is an emerging contributor to the pathogenesis of type 1 diabetes, but candidate therapeutic targets have not been identified in human beta cells. In this study, we examined the role of a secreted factor, GDF15, and found that although it is not required to maintain viability during senescence, it is required to fine-tune gene expression programs involved in the senescence response during DNA damage in human beta cells.
1 型糖尿病(T1D)是一种慢性代谢疾病,由胰腺β细胞的自身免疫破坏引起。β细胞在 T1D 的发展过程中激活各种应激反应,包括衰老,其中包括细胞周期停滞、生存信号和被称为衰老相关分泌表型(SASP)的促炎分泌组。我们之前在一种模拟 T1D 中衰老β细胞特征的 DNA 损伤介导的衰老模型中,将生长分化因子 15(GDF15)鉴定为人类胰岛和人类 EndoC-βH5β细胞中的主要 SASP 因子。可溶性 GDF15 已被证明在与 T1D 相关的各种应激形式下对人和鼠β细胞具有保护作用;因此,我们假设在人类β细胞的 DNA 损伤介导的衰老过程中,分泌的 GDF15 可能发挥生存作用。我们发现,在来自 T1D 供体的胰岛制剂中,升高的 GDF15 分泌与内源性衰老β细胞相关,支持了我们的 DNA 损伤模型的有效性。通过基于抗体的中和,我们发现,衰老的人类胰岛或 EndoC 细胞的生存不需要分泌的内源性 GDF15。相反,GDF15 的中和导致特定衰老相关基因的表达减少,包括 GDF15 本身和生存基因 BCL2 样蛋白 1()。总之,这些数据表明,SASP 因子 GDF15 不需要维持衰老的人类胰岛活力,但需要维持与衰老相关的转录反应。β 细胞衰老已成为 1 型糖尿病发病机制的一个新贡献者,但尚未在人类β细胞中确定候选治疗靶点。在这项研究中,我们研究了一种分泌因子 GDF15 的作用,发现尽管它在衰老过程中不需要维持活力,但在人类β细胞中,在 DNA 损伤过程中,它需要微调与衰老反应相关的基因表达程序。